Search

everythinglearnresearchcommunity

for

Search:↓

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

More research needed to confirm finasteride as standard treatment for FFA.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Finasteride and dutasteride do not significantly change beard thickness in men.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Dutasteride is effective for treating hair loss.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.